InQu is a platform technology for tissue regeneration and is used primarily as an osteobiologic product in spinal fusion applications and is manufactured and marketed in a variety of forms — granules, paste, putty and strip — to meet surgeons’ needs for a variety of surgical applications. InQu has received 510(k) clearances as a bone graft extender and substitute, and since its launch in 2008, it has been used in over 17,000 orthopedic and spinal procedures to date.
Related Articles on Orthopedic Devices:
Hospital for Special Surgery’s Susanne Maher Gets $250k for Osteoarthritis Implant Development
Nanovis Announces Allowance of Key Nanosurface Patents in Canada
SANUWAVE Technology Shown to Proliferate Stem Cells and Form Bone
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
